Nakamura, Kazutaka
Ishiyama, Yudai https://orcid.org/0000-0002-8440-6264
Nemoto, Yuki
Ishihara, Hiroki
Tachibana, Hidekazu
Fukuda, Hironori
Shinmura, Hiroaki
Hashimoto, Yasunobu
Yoshida, Kazuhiko
Iizuka, Junpei
Ishida, Hideki
Kondo, Tsunenori
Takagi, Toshio
Article History
Received: 10 August 2022
Accepted: 12 April 2023
First Online: 27 April 2023
Declarations
:
: Tsunenori Kondo received honoraria from Pfizer, Takeda, MSD, and Ono Pharmaceutical. Toshio Takagi received honoraria from Ono Pharmaceutical. All other authors have no conflicts of interest to declare.
: The study protocol was approved by the institutional ethics review board of the participating organizations (ID: 2020-0108). The present study was performed in accordance with the principles outlined in the Declaration of Helsinki of 1964 and its later amendments. Due to the retrospective observational nature of this study, the need for informed consent was waived.